CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 4,000 shares at an average $33.60 ($134,387)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale COO, CFO sold 4,500 shares at $33.75 ($151,875)
- 4 Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
- 4 Open-market sale Director sold 5,100 shares at $35.80 ($182,580)
- 4 Open-market sale Director sold 3,900 shares at an average $32.55 ($126,935)
- 4 Open-market sale Director sold 16,005 shares at an average $35.79 ($572,868)
- 4 Open-market sale Director sold 44,780 shares at an average $35.92 ($1,608,560)
- 4 Open-market sale President and CEO sold 14,000 shares at an average $35.65 ($499,096)
- 4 Open-market sale Director sold 3,500 shares at an average $34.51 ($120,768)
- 4 Open-market sale Director sold 1,787 shares at $35.67 ($63,742)
- 4 Other disposition 10% owner disposed of 505,000 shares (other)
- 4 Open-market sale Chief Medical Officer sold 4,000 shares at an average $34.83 ($139,309)
- 4 Open-market sale Director sold 600 shares at $35.64 ($21,384)
Page 7 of 10 · 190 filings